Buy J B Chemicals & Pharmaceuticals, target price Rs 2,225: JM Financial
JM Financial maintains a buy call on J B Chemicals & Pharmaceuticals, setting a target price of Rs 2,225. The brokerage believes a ban on ranitidine products, including J B Chemical's Rantac, is unlikely despite concerns over NDMA levels. J B Chemicals, incorporated in 1976, is a Mid Cap company with a market cap of Rs 25050.02 crore.
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
(Disclaimer: Views and recommendations given in this section are the analysts' own and do not represent those of ETMarkets.com. Please consult your financial adviser before taking any position in the stock/s mentioned.)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
41 minutes ago
- News18
Stocks To Watch: HDFC Bank, Suzlon Energy, Tata Steel, BEL, Ambuja, And Others
Last Updated: Stocks to watch: Shares of firms like HDFC Bank, Suzlon Energy, Tata Steel, BEL, Ambuja, and others will be in focus on Monday's trade Stocks to Watch on June 9, 2025: Markets wrapped up the week on a positive note, gaining nearly a percent, supported by favorable domestic cues. In today's trade, shares of HDFC Bank, Suzlon Energy, Tata Steel, BEL, and MCX, among others, will be in focus due to various news developments. The capital markets regulator, SEBI, issued a corrigendum to its interim order in the insider trading case involving IndusInd Bank. Ambuja Cements In its latest annual report, Adani Group's Ambuja Cements highlighted that it contributes nearly 30% of the cement used for India's homes and infrastructure, making it the country's second-largest cement producer. Airtel Telecom operator Airtel has approached over 40 banks, as well as the RBI and NPCI, proposing a collaborative effort to curb digital frauds. The company aims to establish a unified front for sharing intelligence on known fraudulent financial domains. Reliance Infrastructure plans to 'turbocharge' its defense vertical in the coming years, focusing on aircraft upgrade programs. The company recently became the first private sector firm to independently execute a comprehensive aircraft upgrade program, traditionally dominated by public sector units and OEMs. It's targeting opportunities worth Rs 5,000 crore over the next seven to ten years. HDFC Bank's MD and CEO, Sashidhar Jagdishan, has been named in a complaint filed by the Mehta Family through Lilavati Kirtilal Medical Trust. The complaint alleges he received Rs 2.05 crore to harass a current trustee's father. HDFC Bank has dismissed the allegations as baseless and part of an attempt to derail loan recovery efforts. The Government has appointed Sat Pal Bhanoo as the CEO and MD of LIC for a three-month term starting Sunday. This comes after Siddhartha Mohanty completed his tenure, with the Ministry of Finance conveying the instructions on Saturday. Infosys Infosys announced that the Director General of GST Intelligence (DGGI) has closed pre-show cause notice proceedings against the company for FY 2018-19 to FY 2021-22, involving Rs 32,403 crore in GST claims. Tata Steel Tata Steel UK's annual £150 million export to the US faces a potential setback due to compliance issues in the UK-US steel trade agreement. The company has temporarily halted melting and pouring steel in the UK as it transitions Port Talbot from blast furnaces to an electric arc furnace, a requirement for tariff-free trade under current rules. Aditya Birla Group Aditya Birla Group's Indian paints venture has filed an antitrust complaint against Asian Paints for allegedly abusing its market dominance, according to Reuters. The complaint could trigger a legal clash between the two sector rivals. Suzlon Energy Promoters of Suzlon Energy may sell about 20 crore shares in a potential Rs 1,300 crore block deal next week, likely at a 2% discount to the current market price. This update comes after Suzlon reported a nearly five-fold jump in net profit in Q4FY25. Lupin Lupin has received tentative approval from the US FDA for its generic version of Oxcarbazepine Extended-Release (ER) Tablets in 150 mg, 300 mg, and 600 mg strengths. The drug, equivalent to Supernus Pharmaceuticals' Oxtellar XR, will be manufactured at Lupin's Nagpur facility in India. Nazara Technologies Nazara Technologies has completed the acquisition of gaming and entertainment company Smaaash Entertainment Pvt. Ltd. for Rs 126 crore, turning it into a wholly owned subsidiary, the company announced on June 6. Location : New Delhi, India, India First Published: June 09, 2025, 07:40 IST News business » markets Stocks To Watch: HDFC Bank, Suzlon Energy, Tata Steel, BEL, Ambuja, And Others
New Indian Express
an hour ago
- New Indian Express
Kitex managing director alleges harassment by Kerala LDF government, shifts investment to Telangana
KOCHI: Kitex Group managing director Sabu Jacob has alleged that continued harassment by the LDF government forced him to skip Kerala and invest in another state. Addressing the media on Sunday, Sabu claimed his company faced multiple raids and received no support from the LDF government or the industries minister. 'My company was raided multiple times in a month. They couldn't find any violation of rules. The Left government and the minister did not support the business. Everyone knows the reason why I had to shift my Rs 3,500-crore business from Kerala to another state (Telangana),' Sabu said.
Economic Times
an hour ago
- Economic Times
Digit Life Insurance FY25 revenue crosses Rs 1,300 crore in first full year of operations
Digit Life Insurance witnessed substantial growth in FY 2024-25. Its revenue surpassed Rs 1,315.9 crore. The company settled claims worth Rs 2.88 billion. Digit Life improved its claim settlement turnaround time to 1.89 days. The claim settlement ratio reached 99.53%. The company focuses on simplifying products and enhancing trust. Digit Life has served 6.7 million customers with over 4,000 agents. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Mumbai: Go Digit Life Insurance Limited ( Digit Life ), a new-age life insurance company, said its revenue (total gross written premium including reinsurance inward) crossed Rs 1,315.9 crore in FY 2024-25 compared to Rs 492.5 crore in the year-ago company settled claims worth Rs2.88 billion in FY 2024-25 with most claims (worth Rs1.97 billion) being paid under the Group Term Life Insurance category. Digit Life's average TAT of death claims settlement too, improved to 1.89 days during the year from 2 days in FY 23-24 with its claims settlement ratio for the same period hitting 99.53%.Digit Life shared the key figures as part of the second edition of its Transparency Report, a bi-annual exercise where it goes beyond mandatory disclosures and shares various data-led insights and stories.'We are encouraged by the response we have received in the last one year. We now have a robust portfolio of both retail and group products and will look to expand both segments equally in the coming years. We as a company will continue to focus on simplifying life insurance products and improving trust levels in the ecosystem—with the transparency report both as our report card and trust promise," Sabyasachi Sarkar, MD & CEO, Digit Life, company said it has developed a fully automated and secure verification process to identify and check declaration matches and built advanced face matching technology to verify the identity of its customers. It has also developed a claim document classification service that uses an intelligent process to quickly sort claims Life Insurance has served 6.7 million customers since its inception and now has over 4,000 agents and intermediaries. Its Solvency Ratio currently stands at Ventures LLP (promoted by Kamesh Goyal) and FAL Corporation (having Fairfax Financial Holdings Limited as its ultimate parent company) are the promoters of Digit Life Insurance. Fairfax Financial Holdings Limited is listed on the Toronto Stock Exchange in Canada.
